LIGHT LINE MEDICAL, INC. PEER REVIEWED PUBLICATIONS
Rhodes NLR, de la Presa M, Barneck MD, Poursaid AE, Firpo MA, Langell JT. Violet 405 nm light: a novel therapeutic agent against β-lactam-resistant escherichia coli. Lasers Surg. Med. 2015; doi: 10.1002/lsm.22457.
Barneck MD, Rhodes NLR, de la Presa M, Allen JP, Poursaid AE, Nourian MM, Firpo MA, Langell JT. Violet 405 nm light: a novel therapeutic agent against common pathogenic bacteria. Journal of Surgical Research. 2016; doi: 10.1016/j.jss.2016.08.006.
HOSPITAL ACQUIRED INFECTIONS
CATHETER ASSOCIATED URINARY TRACT INFECTIONS (CAUTI)
Hollenbeak CS, Schilling AL. The attributable cost of catheter-associated urinary tract infections in the United States: a systematic review. Elsvier, Inc. 2018; https://doi.org/10.1016/j.ajic.2018.01.015.
ANTIBIOTIC RESISTANT BACTERIA
New CDC vital signs: Lethal, drug-resistant bacteria spreading in U.S. healthcare facilities. Healthmanagement.org. https://healthmanagement.org/c/icu/news/new-cdc-vital-signs-lethal-drug-resistant-bacteria-spreading-in-u-s-healthcare-facilities. Published March 11, 2013.
Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J. The infectious diseases society of America; the epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases society of America. Clinical Infectious Diseases. 2008; 46(2):155–164. https://doi.org/10.1086/524891.